The First At-home Tick Test for Lyme Disease

A new $50 kit lets anyone crush a tick found on their skin or their dog and get a Lyme disease answer in about 30 minutes, without ever leaving the kitchen counter.

Quick Take

LymeAlert is a home test kit that checks a removed tick for Borrelia burgdorferi, the bacteria that causes Lyme disease.
The company says results come back in roughly 15 to 30 minutes and the tick does not need to be alive.
MIT-connected founder Erin Dawicki developed the product with input from Stony Brook University researchers.
The kit has not been evaluated by the Food and Drug Administration (FDA), and it tests the tick, not the person.

What The Test Actually Does

LymeAlert works by crushing the tick, mixing it with a solution, and dipping a test strip into the mixture. Two lines mean the tick carried Borrelia burgdorferi, the bacterium behind Lyme disease. The company’s own product pages describe this crush-and-strip process consistently, and it does not require a live tick, which matters since most people kill the tick before they think to test it.

This is not a blood test and it does not diagnose a person. It only tells you whether the specific tick you found was carrying the bacteria. If it comes back positive, the company suggests talking to a doctor about next steps, but the decision about treatment still rests with a physician.

Founder Erin Dawicki has spoken publicly about developing the test through work connected to Massachusetts Institute of Technology (MIT), with some reporting also pointing to collaboration with Stony Brook University scientists. That academic pedigree gives the concept credibility, even though the finished commercial product is sold directly through the company’s own website rather than through a hospital lab.

Why Coverage Is Spreading Fast This Summer

Outlets including Time, CBS Boston, and ABC7NY have all run launch coverage this year, treating LymeAlert as the first commercially available at-home test built specifically for infected ticks rather than for testing a person’s blood. That framing makes sense. Millions of Americans pull ticks off themselves, kids, and pets every summer with no easy way to know if that particular bug was a threat.

A Suffolk County television report quoted a physician noting that a tick attached for only a few hours carries essentially zero transmission risk, which is a detail the test itself cannot measure. That is an important reality check. Knowing a tick was infected does not by itself tell a family how much danger they actually faced, since attachment time still drives the real infection risk.

The Accuracy Question Nobody Has Fully Answered Yet

The company’s frequently asked questions page claims “lab-level accuracy,” and some company materials cite comparisons to PCR testing, considered a gold standard in laboratories. But the public record provided by the company does not include a published, peer-reviewed validation study with sensitivity and specificity numbers that outside scientists have checked.

That gap matters more in Lyme disease than in almost any other tick-borne illness, because Lyme testing broadly has a rocky track record. A widely cited systematic review of commercial Lyme test kits found an average sensitivity of only 59.5%, with some individual test results as low as 30.6%. A separate meta-analysis found sensitivity for early-stage Lyme disease detection of just 46.3%. Those numbers describe human blood and antibody tests, not tick tests like LymeAlert, but they show how much uncertainty already exists in this corner of medicine before a new product even enters the market.

None of that means LymeAlert doesn’t work as described. It means the strongest evidence available right now comes from the company itself and from friendly launch coverage, not from an independent lab replicating results on blinded field samples. A parent deciding whether to trust a positive or negative result deserves that context before treating the test as a substitute for a doctor’s judgment.

What Buyers Should Understand Before They Order One

The company states plainly that its test has not been evaluated or approved by the FDA, and notably, no at-home tick test is legally required to have that approval since these products test insects, not humans, and are not diagnosing disease in a patient. That is a real legal distinction, but it also means shoppers are relying heavily on the manufacturer’s own quality claims.

LymeAlert is the first at-home test for ticks that can detect whether the tick carries the bacterium that causes Lyme disease.https://t.co/KlUPZqykj9

— Ian Weissman, DO (@DrIanWeissman) August 8, 2026

A $50 kit that flags a dangerous tick sooner could genuinely help a family act faster. The smart move is treating a positive result as a serious prompt to call a doctor, not as a finished diagnosis.